Can phenobarbitone (phenobarbital) cause drug rashes in patients?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 29, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Does Phenobarbital Cause Drug Rashes?

Yes, phenobarbital definitively causes drug rashes, ranging from mild maculopapular eruptions to life-threatening severe cutaneous adverse reactions including Stevens-Johnson syndrome, toxic epidermal necrolysis, and DRESS syndrome (Drug Rash with Eosinophilia and Systemic Symptoms). 1

Types of Cutaneous Reactions

Phenobarbital causes several distinct patterns of skin reactions:

Mild to Moderate Reactions

  • Localized swelling particularly affecting the eyelids, cheeks, or lips, and erythematous dermatitis occur as hypersensitivity reactions, especially in persons with predisposition to asthma, urticaria, or angioedema 1
  • Maculopapular rash is the most common presentation, typically appearing within days to weeks after drug initiation 2, 3

Severe Life-Threatening Reactions

  • Stevens-Johnson syndrome and toxic epidermal necrolysis are rare but potentially fatal reactions that can be caused by phenobarbital 1, 4
  • DRESS syndrome characterized by fever, disseminated rash, lymphadenopathy, eosinophilia, and internal organ involvement (particularly hepatic dysfunction) occurs as a severe multisystem reaction 2, 5
  • These severe reactions may be associated with fever, delirium, and marked degenerative changes in the liver and other organs 1

Timing and Clinical Features

  • Onset typically occurs 2-6 weeks after initiating phenobarbital therapy, consistent with delayed hypersensitivity reactions 2, 3
  • The characteristic triad of DRESS includes fever, skin rash, and internal organ involvement 4
  • Hematologic abnormalities including eosinophilia and thrombocytopenia may accompany the rash 2

Cross-Sensitivity with Other Antiepileptic Drugs

Critical caveat: Phenobarbital demonstrates significant cross-sensitivity with other aromatic antiepileptic drugs, particularly carbamazepine and phenytoin. 6

  • Among patients with phenobarbital rash, 4 out of 5 (80%) were also sensitive to carbamazepine and/or phenytoin 6
  • This cross-reactivity occurs because these are all aromatic anticonvulsants sharing similar metabolic pathways 4
  • If a patient develops a rash from phenobarbital, avoid other aromatic anticonvulsants and consider valproic acid or clobazam as safer alternatives, which showed zero rash occurrences in exposure studies 6

Management Algorithm

Immediate Actions

  • Discontinue phenobarbital immediately upon recognition of any rash, particularly if accompanied by fever, mucosal involvement, or systemic symptoms 2, 3
  • Never rechallenge with phenobarbital after a severe reaction, as this can be fatal 1

Treatment Based on Severity

For mild rashes without systemic symptoms:

  • Apply moderate-potency topical corticosteroids to affected areas 7
  • Use non-sedating antihistamines for daytime symptom control 7
  • Consider sedating antihistamines for nighttime pruritus 7
  • Apply emollients at least once daily 7

For severe reactions (DRESS, SJS, TEN):

  • Hospitalize immediately for intensive care 4
  • Initiate systemic corticosteroids at 2 mg/kg/day 4
  • Consider intravenous immunoglobulin (IVIG) therapy 2, 3
  • Administer broad-spectrum antibiotics to prevent secondary infection 4
  • Provide supportive care with topical antiseptics and thermal water sprays 4

Prevention Strategies

  • Do not use prophylactic corticosteroids or antihistamines when initiating phenobarbital, as this has not proven effective and may mask early warning signs 7
  • Document any phenobarbital rash in the medical record to prevent future re-exposure 8
  • Monitor patients with history of asthma, urticaria, or other allergic conditions more closely, as they are at higher risk 1

Alternative Medication Selection

If phenobarbital causes a rash, switch to a non-aromatic antiepileptic drug rather than another aromatic anticonvulsant due to the 80% cross-reactivity rate 6. Safe alternatives include valproic acid or clobazam, which demonstrated no rash occurrences in clinical exposure studies 6.

References

Research

Antiepileptic Hypersensitivity Syndrome to Phenobarbital: A Case Report.

Iranian journal of allergy, asthma, and immunology, 2019

Research

Cross sensitivity of skin rashes with antiepileptic drugs.

The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques, 1997

Guideline

Management of Cutaneous Reactions to Prozac

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Drug-Induced Itching in Diabetes Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.